Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation

Registry ID

EUCTR2016-001043-39

Source registry

EUCTR

Phase

PHASE4

Sponsor

F. Hoffmann-La Roche AG

Last update

2026-08-16

Conditions

• Renal Transplantation

Summary

Compare the efficacy and the effects on renal function of a regimen of reduced concentration of calcineurin inhibitor (cyclosporine or tacrolimus) and monitored CellCept to regimen of standard concentrations of calcineurin inhibitor and fixed dose CellCept.

Related clinical trials

• The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation
• Pilates Exercises on Balance, Fatigue and Quality of Life
• Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients
• Comparison of the Analgesic Effects of TFPB in Renal Transplantation Surgery
• Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
• Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients

View on source registry